• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample

    ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Lymphedema Treatment Market

    ID: MRFR/HC/49604-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    US Lymphedema Treatment Market Research Report By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery), and By End-User (Hospitals and Clinics, Clinical Research Organizations, Research and Academic Institutes) - Forecast to 2035

    Share:

    Download PDF

    ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Lymphedema Treatment Market Research Report - Forecast to 2035 Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    US Lymphedema Treatment Market Summary

    The United States Lymphedema Treatment market is projected to grow significantly over the next decade.

    Key Market Trends & Highlights

    US Lymphedema Treatment Key Trends and Highlights

    • The market valuation is expected to rise from 123.4 USD Million in 2024 to 290 USD Million by 2035.
    • The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 8.08 percent.
    • Increasing awareness about lymphedema management is likely to drive market growth in the coming years.
    • Growing adoption of advanced treatment modalities due to rising patient demand is a major market driver.

    Market Size & Forecast

    2024 Market Size 123.4 (USD Million)
    2035 Market Size 290 (USD Million)
    CAGR (2025-2035) 8.08%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Jobst, Tactile Medical, Bio Compression, Lympha Press, DME Lymphedema, Juzo, American Lymphedema Framework Project, MediFlex, MediComfort, Sigvaris, Compression Solutions, Kangda Medical, BSN medical, Medi USA, Vitalwear

    US Lymphedema Treatment Market Trends

    The US Lymphedema Treatment Market is experiencing significant growth driven by several key market drivers. One major factor is the increasing prevalence of lymphedema associated with rising cases of cancer and chronic conditions like obesity. More individuals are diagnosed with lymphedema as awareness grows about the condition, leading to higher demand for effective treatment solutions. Additionally, advancements in treatment technologies and methodologies, such as pneumatic compression devices and advanced compression garments, provide patients with better management options, fostering further market expansion. Opportunities in the US market also highlight potential areas for growth and innovation.

    There are opportunities for clinicians and telehealth service providers that stem from more proactive patient education to treat patients. Furthermore, practitioner-patient collaborations can improve focus on lesser-known conditions, which tremendously improves omni-awareness for early diagnosis within the patient demographic and thus claims a larger market share. Recently, the digitization of health systems has proven to be more relevant than before. Telemedicine, as a new branch of healthcare, allows patients to get pre/post-treatment consultations and follow-up visits remotely without visiting hospitals or clinics. Adopting these trends, more telehealth patients are receiving vital treatments in their homes.

    Furthermore, there is a growing emphasis on insurance reimbursements for lymphedema treatments, resulting in increased accessibility to both patients and healthcare providers across the country. Overall, these developments reflect a dynamic landscape in the US Lymphedema Treatment Market, shaped by enhanced awareness, technological innovation, and patient-centered approaches.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    US Lymphedema Treatment Market Drivers

    Market Segment Insights

    Lymphedema Treatment Market Type Insights

    The US Lymphedema Treatment Market is a vital segment within the overall healthcare landscape, focusing primarily on the management and treatment of lymphedema, a condition characterized by localized fluid retention and tissue swelling. It is important to understand the Type segmentation, which is primarily divided into Primary Lymphedema and Secondary Lymphedema. Primary Lymphedema is often seen as a genetic condition where individuals are born with abnormalities in their lymphatic system, leading to chronic swelling.

    This segment, while less common than its counterpart, is crucial as it has a significant emotional and psychological impact on patients, necessitating specialized treatment options that cater to individual needs.

    On the other hand, Secondary Lymphedema is more prevalent and arises from external factors such as surgery, radiation therapy, trauma, or infections like cellulitis. This condition usually emerges in patients who have previously received treatment for cancers of the breast, pelvis, or abdomen. The high incidence of Secondary Lymphedema in cancer survivors is a major growth driver for the US Lymphedema Treatment Market. As advancements in cancer treatment continue to improve survival rates, the demand for effective lymphedema management solutions is likely to rise.

    Both segments are integral to understanding the US Lymphedema Treatment Market, as they reflect the complex interplay of genetics, healthcare practices, and patient lifestyles, helping inform the market's growth and development.

    The statics mentioned regarding treatment options for each Type highlight the diversity in approaches ranging from compression garments to pneumatic devices and surgical interventions. The ongoing Research and Development activities targeting innovative therapies are indicative of the market's potential to expand and adapt to patient needs. Increasing awareness and education about lymphedema have also contributed positively to market growth as healthcare professionals and patients alike begin to recognize the importance of early detection and personalized care plans. The growing emphasis on individualized treatment strategies presents opportunities for the development of specialized products and services tailored to meet patient demands.

    Lymphedema Treatment Market Affected Area Insights

    The Affected Area segment of the US Lymphedema Treatment Market is increasingly significant as it addresses various anatomical regions prone to lymphedema. This market focuses primarily on the Lower Extremity, Upper Extremity, and Genitalia, each representing varying types of lymphedema cases. The Lower Extremity is particularly prevalent due to lifestyle factors and obesity trends in the US, which contribute to a higher incidence of conditions requiring treatment. Conversely, the Upper Extremity is notably impacted by post-cancer treatments, such as mastectomy, leading to an increased need for rehabilitation and management therapies.

    Genitalia lymphedema, though less common, presents a unique challenge, as it affects quality of life significantly and requires specialized treatment protocols. Understanding the dynamics of these anatomical regions is essential for practitioners, ensuring tailored therapy approaches that meet patient needs. As the US Lymphedema Treatment Market continues to expand, these areas will likely drive demand for innovative therapies and products fueled by rising awareness among healthcare providers and patients alike.

    Lymphedema Treatment Market Treatment Insights

    The Treatment segment of the US Lymphedema Treatment Market showcases a diverse range of therapeutic approaches critical for managing this condition. Compression Devices and Bandaging are essential, as they help reduce swelling and improve lymphatic circulation, which is paramount for patients' comfort and mobility. Laser Therapy emerges as a significant option, with its non-invasive nature and ability to stimulate lymphatic vessels, providing relief and enhancing overall treatment efficacy. Drug Therapy plays a crucial role in managing symptoms and preventing complications, often complementing other treatment methods.

    Surgery is regarded as a last resort, catering to patients with severe lymphedema, aiming to improve quality of life by addressing anatomical issues directly. The increasing prevalence of lymphedema in the US government demographics underscores the importance of these treatment modalities, driving demand and innovation in this market segment. As awareness about lymphedema continues to rise, supported by educational initiatives, the Treatment segment is poised to expand, providing patients with more options to manage their condition effectively. The focus on personalized treatment protocols indicates a promising trend in the US Lymphedema Treatment Market.

    Lymphedema Treatment Market End-User Insights

    The End-User segment of the US Lymphedema Treatment Market includes critical contributors such as Hospitals and Clinics, Clinical Research Organizations, and Research and Academic Institutes, each playing a significant role in the market's evolution. Hospitals and Clinics are pivotal, as they provide direct treatment services and often serve as the first point of contact for patients. Their role is crucial due to the growing incidence of lymphedema, with healthcare facilities expanding their offerings to include specialized treatment protocols and advanced technologies.

    Clinical Research Organizations facilitate essential research that drives innovation and development in treatment options, fostering a deeper understanding of lymphedema and leading to improved patient outcomes. Research and Academic Institutes contribute significantly by conducting studies that enhance the overall knowledge base and inform best practices in treatment. The interplay between these sectors not only enhances the quality of care provided but also fuels market growth by addressing the unmet needs of lymphedema patients, hence reflecting the importance of collaboration across these various entities in addressing this healthcare challenge.

    Overall, the End-User segment is instrumental in shaping the landscape of lymphedema treatment in the US.

    Get more detailed insights about US Lymphedema Treatment Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The US Lymphedema Treatment Market is witnessing a significant evolution characterized by a competitive landscape that is shaped by innovative product offerings, advancements in technology, and evolving patient needs. The market is predominantly driven by increasing prevalence rates of lymphedema, heightened awareness of the condition, and advancements in treatment options. As healthcare providers and patients seek effective solutions, companies are focusing on developing comprehensive treatment protocols that encompass physical therapy, compression garments, and devices designed for lymphatic drainage.

    This competitive landscape also sees key players striving to enhance their market share through strategic collaborations, mergers, and acquisitions, along with a keen emphasis on expanding their product portfolios to meet the varying demands of a diverse patient base. Jobst plays a pivotal role in the US Lymphedema Treatment Market, renowned for its innovative compression therapy solutions targeted at managing lymphedema effectively. With a strong emphasis on patient comfort and compliance, Jobst's products incorporate advanced fabrics and technologies that ensure optimal compression while being user-friendly.

    The company's established market presence is bolstered by a well-recognized brand among healthcare providers and patients alike. Jobst's strengths lie in its comprehensive range of compression garments tailored to meet specific medical needs, ensuring individuals grappling with the condition can access appropriate and effective solutions. 

    Additionally, their commitment to ongoing product development reflects an understanding of market dynamics and patient feedback, positioning them as a key player within the competitive landscape. Tactile Medical has emerged as another significant contender in the US Lymphedema Treatment Market, focusing on high-quality, innovative solutions that encompass both products and services aimed at managing lymphedema. The company specializes in advanced pneumatic compression devices that facilitate lymphatic drainage, offering patients an effective option for treatment that can be administered in the comfort of their own homes.

    Tactile Medical's strengths lie in its robust presence in the healthcare market, supplemented by a strong reputation among healthcare professionals for the reliability and performance of its devices. This is further enhanced through various partnerships and potential mergers or acquisitions aimed at expanding service offerings and improving patient access to their solutions. Their comprehensive approach to patient education and support also differentiates them in a competitive environment, as Tactile Medical invests in empowering patients with the necessary knowledge and resources to manage their condition effectively.

    Key Companies in the US Lymphedema Treatment Market market include

    Industry Developments

    Market Segmentation

    Lymphedema Treatment Market Type Outlook

    • Primary Lymphedema
    • Secondary Lymphedema

    Lymphedema Treatment Market End-User Outlook

    • Hospitals and Clinics
    • Clinical Research Organizations
    • Research & Academic Institutes

    Lymphedema Treatment Market Treatment Outlook

    • Compression Devices & Bandaging
    • Laser Therapy
    • Drug Therapy & Surgery

    Lymphedema Treatment Market Affected Area Outlook

    • Lower Extremity
    • Upper Extremity
    • Genitalia

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 113.4 (USD Million)
    Market Size 2024 123.38 (USD Million)
    Market Size 2035 290.0 (USD Million)
    Compound Annual Growth Rate (CAGR) 8.079% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Million
    Key Companies Profiled Jobst, Tactile Medical, Bio Compression, Lympha Press, DME Lymphedema, Juzo, American Lymphedema Framework Project, MediFlex, MediComfort, Sigvaris, Compression Solutions, Kangda Medical, BSN medical, Medi USA, Vitalwear
    Segments Covered Type, Affected Area, Treatment, End-User
    Key Market Opportunities Increasing prevalence of lymphedema cases, Technological advancements in treatment devices, Growing awareness and patient education, Expansion of home care solutions, Rising adoption of telemedicine services
    Key Market Dynamics Increasing prevalence of lymphedema, growing geriatric population, advancements in treatment technologies, rising awareness and education, favorable reimbursement policies
    Countries Covered US

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the US Lymphedema Treatment Market in 2024?

    The US Lymphedema Treatment Market is expected to be valued at 123.38 USD Million in 2024.

    What will the market value of the US Lymphedema Treatment Market be by 2035?

    By 2035, the US Lymphedema Treatment Market is projected to reach a value of 290.0 USD Million.

    What is the expected compound annual growth rate (CAGR) for the US Lymphedema Treatment Market from 2025 to 2035?

    The market is anticipated to have a CAGR of 8.079% from 2025 to 2035.

    Which segment of the US Lymphedema Treatment Market holds a larger market share?

    The Secondary Lymphedema segment is expected to be valued at 78.38 USD Million in 2024, indicating a larger market share compared to Primary Lymphedema.

    What is the projected market size for Primary Lymphedema by 2035?

    The market size for Primary Lymphedema is expected to reach 105.0 USD Million by 2035.

    Who are the key players in the US Lymphedema Treatment Market?

    Key players in the market include Jobst, Tactile Medical, Bio Compression, Lympha Press, and Juzo.

    What are the expected applications that drive growth in the US Lymphedema Treatment Market?

    The growth in the market is driven by increasing awareness and treatment options for both primary and secondary lymphedema.

    What are the major challenges facing the US Lymphedema Treatment Market?

    Challenges include awareness gaps among healthcare providers and patients regarding lymphedema management.

    What opportunities exist for growth in the US Lymphedema Treatment Market?

    Opportunities for growth include advancements in treatment technologies and increasing incidence rates of lymphedema.

    How is the market expected to perform in the next decade?

    The market is expected to experience significant growth with a steady increase in demand for lymphedema treatments and management solutions.

    1. "TABLE OF CONTENTS
    2. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook
    3. MARKET
    4. INTRODUCTION
      1. Definition
      2. Scope of the study
        1. Research
    5. Objective
      1. Assumption
        1. Limitations
    6. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
    7. Primary Research
      1. Primary Interviews and Information Gathering Process
        1. Breakdown of Primary Respondents
      2. Forecasting Model
    8. Market Size Estimation
      1. Bottom-Up Approach
        1. Top-Down Approach
      2. Data Triangulation
      3. Validation
    9. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    10. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's
    11. Five Forces Analysis
      1. Bargaining Power of Suppliers
        1. Bargaining
    12. Power of Buyers
      1. Threat of New Entrants
        1. Threat of Substitutes
        2. Intensity of Rivalry
      2. COVID-19 Impact Analysis
    13. Market Impact Analysis
      1. Regional Impact
        1. Opportunity and
    14. Threat Analysis
    15. US LYMPHEDEMA TREATMENT MARKET, BY TYPE (USD MILLION)
      1. Primary Lymphedema
      2. Secondary Lymphedema
    16. US LYMPHEDEMA
    17. TREATMENT MARKET, BY AFFECTED AREA (USD MILLION)
      1. Lower Extremity
      2. Upper Extremity
      3. Genitalia
    18. US LYMPHEDEMA TREATMENT MARKET,
    19. BY TREATMENT (USD MILLION)
      1. Compression Devices & Bandaging
    20. Laser Therapy
      1. Drug Therapy & Surgery
    21. US LYMPHEDEMA TREATMENT
    22. MARKET, BY END-USER (USD MILLION)
      1. Hospitals and Clinics
      2. Clinical
    23. Research Organizations
      1. Research & Academic Institutes
    24. COMPETITIVE LANDSCAPE
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Lymphedema
    25. Treatment Market
      1. Competitive Benchmarking
      2. Leading Players
    26. in Terms of Number of Developments in the Lymphedema Treatment Market
    27. Key developments and growth strategies
      1. New Product Launch/Service
    28. Deployment
      1. Merger & Acquisitions
        1. Joint Ventures
      2. Major Players Financial Matrix
        1. Sales and Operating Income
        2. Major Players R&D Expenditure. 2023
    29. COMPANY PROFILES
      1. Jobst
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      2. Tactile Medical
        1. Financial Overview
        2. Products
    30. Offered
      1. Key Developments
        1. SWOT Analysis
    31. Key Strategies
      1. Bio Compression
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      2. Lympha Press
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT
    32. Analysis
      1. Key Strategies
      2. DME Lymphedema
        1. Financial
    33. Overview
      1. Products Offered
        1. Key Developments
    34. SWOT Analysis
      1. Key Strategies
      2. Juzo
        1. Financial
    35. Overview
      1. Products Offered
        1. Key Developments
    36. SWOT Analysis
      1. Key Strategies
      2. American Lymphedema Framework
    37. Project
      1. Financial Overview
        1. Products Offered
    38. Key Developments
      1. SWOT Analysis
        1. Key Strategies
    39. MediFlex
      1. Financial Overview
        1. Products Offered
    40. Key Developments
      1. SWOT Analysis
        1. Key Strategies
    41. MediComfort
      1. Financial Overview
        1. Products Offered
        2. Key Developments
        3. SWOT Analysis
        4. Key Strategies
      2. Sigvaris
        1. Financial Overview
        2. Products
    42. Offered
      1. Key Developments
        1. SWOT Analysis
    43. Key Strategies
      1. Compression Solutions
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT
    44. Analysis
      1. Key Strategies
      2. Kangda Medical
    45. Financial Overview
      1. Products Offered
        1. Key Developments
        2. SWOT Analysis
        3. Key Strategies
      2. BSN medical
        1. Financial Overview
        2. Products Offered
    46. Key Developments
      1. SWOT Analysis
        1. Key Strategies
      2. Medi USA
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key
    47. Strategies
      1. Vitalwear
        1. Financial Overview
    48. Products Offered
      1. Key Developments
        1. SWOT Analysis
        2. Key Strategies
    49. APPENDIX
      1. References
    50. Related Reports
    51. 2035 (USD BILLIONS)
    52. & FORECAST, BY AFFECTED AREA, 2019-2035 (USD BILLIONS)
    53. TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT, 2019-2035 (USD BILLIONS)
    54. END-USER, 2019-2035 (USD BILLIONS)
    55. BY TYPE
    56. US LYMPHEDEMA TREATMENT MARKET ANALYSIS BY END-USER
    57. CRITERIA OF LYMPHEDEMA TREATMENT MARKET
    58. IMPACT ANALYSIS: LYMPHEDEMA TREATMENT MARKET
    59. ANALYSIS: LYMPHEDEMA TREATMENT MARKET
    60. TREATMENT MARKET
    61. SHARE)
    62. Billions)
    63. SHARE)
    64. (USD Billions)
    65. (% SHARE)
    66. (USD Billions)
    67. SHARE)
    68. Billions)

    US Lymphedema Treatment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Report Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study

    Chemicals and Materials